0001127602-20-031074.txt : 20201210 0001127602-20-031074.hdr.sgml : 20201210 20201210162501 ACCESSION NUMBER: 0001127602-20-031074 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201209 FILED AS OF DATE: 20201210 DATE AS OF CHANGE: 20201210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berge Terence M CENTRAL INDEX KEY: 0001635424 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39218 FILM NUMBER: 201380895 MAIL ADDRESS: STREET 1: C/O CONMED CORPORATION STREET 2: 525 FRENCH ROAD CITY: UTICA STATE: NY ZIP: 13502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONMED CORP CENTRAL INDEX KEY: 0000816956 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 160977505 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 FRENCH ROAD CITY: UTICA STATE: NY ZIP: 13502 BUSINESS PHONE: 315-624-3208 MAIL ADDRESS: STREET 1: 525 FRENCH ROAD CITY: UTICA STATE: NY ZIP: 13502 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-12-09 0000816956 CONMED CORP CNMD 0001635424 Berge Terence M C/O CONMED CORPORATION 525 FRENCH ROAD UTICA NY 13502 1 VP-Corporate Controller Common Stock 2020-12-09 4 S 0 2870 100.64 D 3042 D Common Stock 2020-12-09 4 S 0 2038 101.43 D 1004 D Common Stock 2020-12-09 4 M 0 5400 59.96 A 6404 D Common Stock 2020-12-09 4 S 0 4593 100.387 D 1811 D Common Stock 2020-12-09 4 S 0 807 101.47 D 1004 D Options To Purchase Common Stock 59.96 2020-12-09 4 M 0 5400 0 D 2028-03-01 Common Stock 5400 8100 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.27 to $100.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.04 to $101.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.06 to $101.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. /s/ Sarah M. Oliker for Terence M. Berge by Power of Attorney 2020-12-10